Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH)—previously known as nonalcoholic ...

Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) has become the first drug to be approved by the US Food and Drug Administration (FDA) as a treatment for noncirrhotic nonalcoholic ...

Barker et al [43] found improvement in steatosis, lobular inflammation, and portal/lobular fibrosis in the majority of the 19 patients studied. In addition, histopathologic criteria for NASH were ...

pentoxifylline leads to a significant reduction in the AST and ALT levels in patients with NASH. This improvement correlates with histological resolution of steatosis, inflammation and fibrosis ...

The test is not for use in the diagnosis of NASH or for the staging of fibrosis. Please contact Siemens Healthineers directly for availability. The Enhanced Liver Fibrosis (ELF TM) Test is a non ...